Sanofi, 10% Owner at REGENERON PHARMACEUTICALS INC (REGN), bought 60,595 shares at $479.45 ($29.0M) on 2017-08-23, disclosed to the SEC on 2017-08-25.
Open-market purchase of $29.0M REGN by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $475.97 | 1,900 | $904K | 3.1% |
| 2 | $477.35 | 9,600 | $4.6M | 15.8% |
| 3 | $478.34 | 12,186 | $5.8M | 20.1% |
| 4 | $479.45 | 23,872 | $11.4M | 39.4% |
| 5 | $480.37 | 13,037 | $6.3M | 21.6% |
| Total | $478.98 avg | 60,595 |
| $29.0M |
| 100% |
| Filing → |
| ICVX | BUY | 2021-08-02 | $1.0M | — | Filing → |
| INZY | BUY | 2020-07-29 | $1.3M | — | Filing → |
| REGN | SELL | 2020-06-11 | $143.7M | — | Filing → |